Conceptio › Archive › HAL (France)
HAL (France)open access

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
0
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 669973
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.